Doctor profile · Federal record

Dr. Nawid Sarwari, M.D.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Anaheim, CA

  • NPI 1649698630
  • Accepts Medicare
  • 12 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
1801 W Romneya Dr Ste 103
Anaheim, CA 928011824
(714) 399-0620
fax (714) 399-0621
Additional location
999 N Tustin Ave Ste 212
Santa Ana, CA 927056506
(714) 542-0102
fax (657) 229-6879
Mailing address
18000 Studebaker RD Ste 800
Cerritos, CA 907032671

Credentials & registration

NPPES · NUCC
NPI registered
April 2014 — 12 yrs on file
Profile last updated
July 8, 2020
Year of graduation
2014 — 12 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
California #A165978

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1649698630. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
1,336
Distinct HCPCS
10
Medicare allowed
$60,752
HCPCS Description Services Patients Avg allowed
J2405 Injection, ondansetron hydrochloride, per 1 mg 336 11 $0
J1100 Injection, dexamethasone sodium phosphate, 1 mg 244 14 $0
99214 Established patient office or other outpatient visit, 30-39 minutes 196 103 $138
36415 Insertion of needle into vein for collection of blood sample 167 111 $8
99213 Established patient office or other outpatient visit, 20-29 minutes 122 92 $98
96372 Injection of drug or substance under skin or into muscle 46 16 $15
96413 Administration of chemotherapy into vein, 1 hour or less 46 19 $151
36591 Collection of blood sample from implanted device 31 13 $31
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 29 15 $74
J1200 Injection, diphenhydramine hcl, up to 50 mg 27 16 $1

In context: peer comparison

Among 4 peers in this city , average services per provider: 80. This provider delivers 17× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$6,681
Transactions
173
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 26 $1,468.46
Astellas Pharma US Inc 7 $399.41
Merck Sharp & Dohme LLC 13 $307.71
Eisai Inc. 12 $295.52
PFIZER INC. 18 $286.46
Incyte Corporation 12 $271.17
Daiichi Sankyo Inc. 9 $247.68
ABBVIE INC. 16 $242.44
Janssen Biotech, Inc. 11 $217.75
Takeda Pharmaceuticals U.S.A., Inc. 8 $193.75
SOBI, INC 13 $186.56
AstraZeneca Pharmaceuticals LP 7 $176.63
GlaxoSmithKline, LLC. 10 $146.25
BeiGene USA, Inc. 5 $136.23
Gilead Sciences, Inc. 6 $132.73

By nature of payment

Food and Beverage
$5,194
Long term medical supply or device loan
$1,097
Education
$390

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
669
Patients
144
Total drug cost
$1,558,869
Drug Type Claims Patients Total cost
Anastrozole Generic 154 52 $9,258
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 49 24 $1,326
Eliquis (Apixaban) Brand 43 0 $27,684
Letrozole Generic 42 12 $3,519
Prednisone Generic 42 11 $258
Imbruvica (Ibrutinib) Brand 41 0 $643,330
Xtandi (Enzalutamide) Brand 40 0 $586,760
Orgovyx (Relugolix) Brand 36 0 $93,733
Acyclovir Generic 34 0 $834
Imatinib Mesylate Generic 34 0 $63,387

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Nawid Sarwari's medical specialty?
Dr. Nawid Sarwari practices Hematology & Oncology Physician in Anaheim, CA.
Where does Dr. Nawid Sarwari practice?
Dr. Nawid Sarwari practices at 1801 W Romneya Dr Ste 103, Anaheim, CA 928011824. Office phone: 7143990620.
What is Dr. Nawid Sarwari's NPI?
Dr. Nawid Sarwari's National Provider Identifier (NPI) is 1649698630, issued by NPPES.
Does Dr. Nawid Sarwari accept Medicare assignment?
Yes. Dr. Nawid Sarwari accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Nawid Sarwari commonly perform?
Top Medicare-reported procedures in 2023: Injection, ondansetron hydrochloride, per 1 mg (HCPCS J2405); Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.